Why drug prices will continue to roil the waters-and why Scott Gottlieb, MD, will be in the center of the action

Greene, J.; Greene, J

Home

>

Node

>

Subnode

Why drug prices will continue to roil the waters-and why Scott Gottlieb, MD, will be in the center of the action

Greene, J.

Managed Care 27(12): 23-28

2018

ISSN/ISBN: 1062-3388

PMID: 30620322

Document Number: 694958

We'll see what happens to the administration's Part B proposal. Congress is not likely to take bold action, partly because drugmakers are a strong influence on both parties. That leaves the FDA and Administrator Scott Gottlieb, MD, as major players in efforts to rein in drug prices.